Trump Chooses Erica Schwartz for CDC Leadership Amid Vaccine Controversy
Donald Trump announced the nomination of Erica Schwartz as director of the CDC, following significant leadership changes. Schwartz, who was deputy surgeon general, played a key role in the federal COVID response. The decision comes as the White House shifts focus from controversial vaccine policies to popular issues like drug pricing and food safety.
In a significant leadership move, former U.S. President Donald Trump announced the nomination of Erica Schwartz for the role of director at the Centers for Disease Control and Prevention. Schwartz previously served as deputy surgeon general during the tumultuous COVID-19 pandemic and played a crucial part in the federal response efforts.
The nomination, considered more conventional, is viewed as an attempt by the White House to pivot from Health Secretary Robert F. Kennedy Jr.'s contentious vaccine policies towards broader public health topics like drug pricing and food safety. This shift comes amid Republican preparations for the challenging November midterm elections.
If confirmed, Schwartz will helm the CDC, responsible for handling pressing public health issues domestically and internationally. Schwartz's leadership has been lauded by former health officials, particularly for her pandemic preparedness and her non-controversial stance on vaccine policies, setting a hopeful tone for the agency's future.
ALSO READ
-
Tumultuous Turnover: Trump Nominates Erica Schwartz for CDC Leadership
-
Trump Nominates Erica Schwartz as CDC Director Amid Vaccine Policy Controversies
-
Trump Appoints Erica Schwartz to Lead CDC
-
Trump says he's nominating Erica Schwartz, former deputy surgeon general, to serve as CDC director, reports AP.
-
Leadership Changes at CDC: Erica Schwartz Considered for Top Role